Grant: Operating Grant: Priority Announcement (IHSPR)
University of Calgary
$74,876.00
Coronary angiography and revascularization for patients with Stage 4 and 5 non-dialysis chronic kidney disease: A decision analysis
FY 2009-10
Summary
Chronic kidney disease (CKD) is associated with a high risk of cardiovascular morbidity and mortality. Despite the severity of atherosclerotic disease and high burden of cardiovascular risk associated with CKD, patients with CKD are less likely to receive proven therapeutic interventions including coronary angiography and coronary revascularization following a cardiovascular event. The risk of contrast nephropathy and its consequences, including mortality and progression to end-stage renal disease (ESRD) requiring dialysis, may influence decisions to proceed with or without coronary angiography. Given the complexity of decisions that must balance these risks and benefits, and the absence of data from randomized controlled trials directly addressing this question, formal analyses that address the appropriateness of clinical decisions surrounding the use of coronary angiography in patients with CKD are warranted. The objectives of this study are to create and validate models to accurately predict the proportion of patients experiencing contrast nephropathy, death, temporary dialysis, and permanent dialysis/ESRD based on data from a cohort of patients from Alberta with CKD Stage 4 and 5 who have received coronary angiography. These models will be used to determine the clinical outcomes (including survival, quality of life and requirement for dialysis/ESRD) and costs associated with a strategy of aggressive coronary angiography in patients with Stage 4 and 5 nondialysis CKD, compared with a strategy of angiographic avoidance. This will provide valuable information for patients, physicians, and health care decision makers and help inform clinical decisions about the treatment of patients with Stage 4 and 5 CKD.
Department
Program
Operating Grant: Priority Announcement (IHSPR)
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
205020
Name
James Matthew T
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Clinical Investigation - C: Digestive, Endocrine and Excretory Systems
Projecttitle
Coronary angiography and revascularization for patients with Stage 4 and 5 non-dialysis chronic kidney disease: A decision analysis
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$74,876
Cihrequipment2
$0
Programname2
Operating Grant: Priority Announcement (IHSPR)
Keyworddelim
Decision Analysis; Economic Evaluation; Health Services Research
Abstract
Chronic kidney disease (CKD) is associated with a high risk of cardiovascular morbidity and mortality. Despite the severity of atherosclerotic disease and high burden of cardiovascular risk associated with CKD, patients with CKD are less likely to receive proven therapeutic interventions including coronary angiography and coronary revascularization following a cardiovascular event. The risk of contrast nephropathy and its consequences, including mortality and progression to end-stage renal disease (ESRD) requiring dialysis, may influence decisions to proceed with or without coronary angiography. Given the complexity of decisions that must balance these risks and benefits, and the absence of data from randomized controlled trials directly addressing this question, formal analyses that address the appropriateness of clinical decisions surrounding the use of coronary angiography in patients with CKD are warranted. The objectives of this study are to create and validate models to accurately predict the proportion of patients experiencing contrast nephropathy, death, temporary dialysis, and permanent dialysis/ESRD based on data from a cohort of patients from Alberta with CKD Stage 4 and 5 who have received coronary angiography. These models will be used to determine the clinical outcomes (including survival, quality of life and requirement for dialysis/ESRD) and costs associated with a strategy of aggressive coronary angiography in patients with Stage 4 and 5 nondialysis CKD, compared with a strategy of angiographic avoidance. This will provide valuable information for patients, physicians, and health care decision makers and help inform clinical decisions about the treatment of patients with Stage 4 and 5 CKD.
Competitiondate
200909
Approvedterm2
1 yr 0 mth
Pinamesdelim
James, Matthew T; Manns, Braden J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $74,876~ $0~